Machine learning approaches identify chemical features for stage-specific antimalarial compounds
A. van Heerden, G. Turon, M. Duran-Frigola, N. Pillay, L.-M. Birkholtz
Abstract
Efficacy data from diverse chemical libraries, screened against the various stages of the malaria parasite Plasmodium falciparum, including asexual blood stage (ABS) parasites and transmissible gametocytes, serves as a valuable reservoir of information on the chemical space of compounds that are either active (or not) against the parasite. We postulated that this data can be mined to define chemical features associated with sole ABS activity and/or those that provide additional life cycle activity profiles like gametocytocidal activity. Additionally, this information could provide chemical features associated with inactive compounds, which could eliminate any future unnecessary screening of similar chemical analogues. Therefore, we aimed to use machine learning to identify the chemical space associated with stage-specific antimalarial activity. We collected data from various chemical libraries that were screened against the asexual (126 374 compounds) and sexual (gametocyte) stages of the parasite (93 941 compounds), calculated the compounds molecular fingerprints and trained machine learning models to recognize stage-specific active and inactiv compounds. We were able to build several models that predicts compound activity against ABS and dual-activity against ABS and gametocytes, with Support Vector Machines (SVM) showing superior abilities with high recall (90% and 66%) and low false positive predictions (15% and 1%). This allowed identification of chemical features enriched in active and inactive populations, an important outcome that could be mined for essential chemical features to streamline hit-to-lead optimization strategies of antimalarial candidates. The predictive capabilities of the models held true in diverse chemical spaces, indicating that the ML models are therefore robust and can serve as a prioritization tool to drive and guide phenotypic screening and medicinal chemistry programs. For Table of Contents Graphic Only O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=73 SRC="FIGDIR/small/553339v1_ufig1.gif" ALT="Figure 1"> View larger version (17K): org.highwire.dtl.DTLVardef@6c03d2org.highwire.dtl.DTLVardef@16eeefborg.highwire.dtl.DTLVardef@bcd95org.highwire.dtl.DTLVardef@e60be4_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Machine Learning connects structure, bitterness & mechanism to antimalarial activity
S. Sambu·bioRxiv·Sep 8, 2023
- Screening of a chemogenetic library unveils dual-stage antimalarials with low cytotoxicity
Laura Torres, Matthew E. Fishbaugher, … Gabriel Mitchell·bioRxiv·Oct 26, 2025
- Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box
J. Reader, M. E. van der Watt, … L.-M. Birkholtz·bioRxiv·Jun 5, 2020
- Screening the Pathogen Box Compounds for Activity Against Plasmodium falciparum Sporozoite Motility
S. kanatani, R. Elahi, … P. Sinnis·bioRxiv·Mar 30, 2022
- Functional Phenotyping of MMV Pandemic Response Box Identifies Stage-specific inhibitors Against Blood stage Plasmodium
T P Akhila, K M Darsana, Rajesh Chandramohanadas·ACS Infectious DiseasesPeer-reviewed·Jul 11, 2025
- Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds
M. G. Dans, G. E. Weiss, … P. R. Gilson·bioRxiv·Sep 13, 2019